because there currently is no uniformly successful and acceptable medical therapy for endometriosis , we examined the effects of 6 months of nasal administration ( 500 micrograms every 12 hours ) of the agonistic analog of gnrh , nafarelin , on clinical signs and symptoms and hormonal profiles in eight women with endometriosis .
C0064906
nafarelin
C0014175
endometriosis